{"product_id":"helicobacter-pylori-selective-agar","title":"Helicobacter Pylori Selective Agar Base | Ausamics","description":"\u003c!--\n  AuSaMicS Life Science(tm) | Helicobacter pylori Selective Medium Base | AS-1249\n  4-Tab Embeddable HTML | March 2026\n--\u003e\n\u003cstyle\u003e\n#au-hp1249{\n  --g1:#1A4731;--g2:#2D6A4F;--ga:#EAF4EE;--gb:#F5FAF7;\n  --bk:#111827;--ch:#374151;--gx:#6B7280;--lt:#E5E7EB;--wh:#FFFFFF;\n  --rd:#991B1B;--or:#B45309;--bl:#1E40AF;\n  font-family:'Segoe UI',system-ui,sans-serif;font-size:14px;color:var(--bk);\n  max-width:980px;margin:0 auto;background:var(--wh);\n  border:1px solid var(--lt);border-radius:4px;overflow:hidden;\n}\n#au-hp1249 .hdr{background:var(--g1);padding:26px 32px 22px;display:flex;align-items:flex-start;justify-content:space-between;gap:24px}\n#au-hp1249 .hdr-l{flex:1}\n#au-hp1249 .cat{font-size:10px;font-weight:700;letter-spacing:.12em;color:#7EC8A0;text-transform:uppercase;margin-bottom:6px}\n#au-hp1249 .pname{font-size:22px;font-weight:800;color:var(--wh);line-height:1.2;margin-bottom:3px}\n#au-hp1249 .psub{font-size:12px;color:#9FD4B4;font-style:italic;margin-bottom:14px}\n#au-hp1249 .badges{display:flex;flex-wrap:wrap;gap:6px}\n#au-hp1249 .badge{font-size:10px;font-weight:600;padding:3px 10px;border:1px solid rgba(255,255,255,.22);border-radius:2px;color:rgba(255,255,255,.82);background:rgba(255,255,255,.07)}\n#au-hp1249 .hdr-r{text-align:right;flex-shrink:0}\n#au-hp1249 .brand{font-size:13px;font-weight:700;color:var(--wh);letter-spacing:.04em}\n#au-hp1249 .brand-s{font-size:9px;color:#7EC8A0;letter-spacing:.1em;text-transform:uppercase;margin-top:2px}\n#au-hp1249 .strip{display:grid;grid-template-columns:repeat(5,1fr);border-bottom:1px solid var(--lt)}\n#au-hp1249 .si{padding:10px 16px;border-right:1px solid var(--lt);background:var(--gb)}\n#au-hp1249 .si:last-child{border-right:none}\n#au-hp1249 .sl{font-size:9px;font-weight:700;color:var(--gx);letter-spacing:.1em;text-transform:uppercase;margin-bottom:3px}\n#au-hp1249 .sv{font-size:12.5px;font-weight:700;color:var(--bk)}\n#au-hp1249 .tabs{display:flex;border-bottom:2px solid var(--lt);background:var(--wh)}\n#au-hp1249 .tab{padding:12px 22px;font-size:12px;font-weight:600;cursor:pointer;border:none;background:none;color:var(--gx);border-bottom:2px solid transparent;margin-bottom:-2px;transition:color .15s,border-color .15s}\n#au-hp1249 .tab:hover{color:var(--g2)}\n#au-hp1249 .tab.active{color:var(--g1);border-bottom-color:var(--g1)}\n#au-hp1249 .panel{display:none;padding:28px 32px 36px}\n#au-hp1249 .panel.active{display:block}\n#au-hp1249 .sh{font-size:10px;font-weight:700;letter-spacing:.12em;text-transform:uppercase;color:var(--wh);background:var(--g1);padding:5px 12px;margin:26px 0 12px;display:inline-block}\n#au-hp1249 .sh:first-child{margin-top:0}\n#au-hp1249 p{font-size:13.5px;color:var(--ch);line-height:1.72;margin:0 0 14px}\n#au-hp1249 .kv{width:100%;border-collapse:collapse;margin-bottom:18px;font-size:13px}\n#au-hp1249 .kv tr{border-bottom:1px solid var(--lt)}\n#au-hp1249 .kv tr:last-child{border-bottom:none}\n#au-hp1249 .kv td{padding:7px 12px 7px 0;vertical-align:top}\n#au-hp1249 .kv td:first-child{width:34%;font-weight:600;color:var(--gx);padding-right:18px}\n#au-hp1249 .dt{width:100%;border-collapse:collapse;font-size:12.5px;margin-bottom:18px}\n#au-hp1249 .dt thead tr{background:var(--g1)}\n#au-hp1249 .dt thead th{color:var(--wh);padding:8px 12px;text-align:left;font-size:10px;font-weight:700;letter-spacing:.08em;text-transform:uppercase}\n#au-hp1249 .dt tbody tr:nth-child(even){background:var(--gb)}\n#au-hp1249 .dt tbody td{padding:7px 12px;border-bottom:1px solid var(--lt);color:var(--ch);vertical-align:top}\n#au-hp1249 .cards{display:grid;grid-template-columns:repeat(3,1fr);gap:14px;margin-bottom:22px}\n#au-hp1249 .card{border:1px solid var(--lt);border-top:3px solid var(--g2);padding:16px;border-radius:2px}\n#au-hp1249 .card-icon{font-size:22px;margin-bottom:8px}\n#au-hp1249 .card-title{font-size:11px;font-weight:700;color:var(--g1);text-transform:uppercase;letter-spacing:.08em;margin-bottom:7px}\n#au-hp1249 .card-body{font-size:12.5px;color:var(--ch);line-height:1.6}\n#au-hp1249 .incub{display:grid;grid-template-columns:1fr 1fr;gap:14px;margin-bottom:18px}\n#au-hp1249 .ib{border:1px solid var(--g2);background:var(--ga);padding:16px 20px;border-radius:2px}\n#au-hp1249 .ib .lbl{font-size:9px;font-weight:700;letter-spacing:.1em;text-transform:uppercase;color:var(--g2);margin-bottom:6px}\n#au-hp1249 .ib .temp{font-size:22px;font-weight:800;color:var(--g1);line-height:1}\n#au-hp1249 .ib .dur{font-size:12px;color:var(--ch);margin-top:5px}\n#au-hp1249 .steps{list-style:none;padding:0;margin:0 0 18px}\n#au-hp1249 .steps li{display:flex;gap:12px;padding:9px 0;border-bottom:1px solid var(--lt);font-size:13px;color:var(--ch);line-height:1.55}\n#au-hp1249 .steps li:last-child{border-bottom:none}\n#au-hp1249 .sn{flex-shrink:0;width:24px;height:24px;background:var(--g1);color:var(--wh);border-radius:50%;display:flex;align-items:center;justify-content:center;font-size:10px;font-weight:700;margin-top:1px}\n#au-hp1249 .two-col{display:grid;grid-template-columns:1fr 1fr;gap:26px;margin-bottom:18px}\n#au-hp1249 .pass{display:inline-block;background:#D1FAE5;color:#065F46;font-size:10px;font-weight:700;padding:2px 9px;border-radius:2px}\n#au-hp1249 .conform{display:inline-block;background:#DBEAFE;color:var(--bl);font-size:10px;font-weight:700;padding:2px 9px;border-radius:2px}\n#au-hp1249 .sig{display:grid;grid-template-columns:1fr 1fr;gap:26px;margin-top:26px}\n#au-hp1249 .sigb{border-top:2px solid var(--g1);padding-top:10px}\n#au-hp1249 .sigb .sname{font-size:13px;font-weight:700;color:var(--bk)}\n#au-hp1249 .sigb .srole{font-size:11px;color:var(--gx)}\n#au-hp1249 .sigb .sdate{font-size:11px;color:var(--gx);margin-top:4px}\n#au-hp1249 .note{border-left:3px solid var(--g2);background:var(--ga);padding:11px 16px;font-size:12.5px;color:var(--ch);margin-bottom:18px;line-height:1.65}\n#au-hp1249 .warn{border-left:3px solid var(--or);background:#FFFBEB;padding:11px 16px;font-size:12.5px;color:#78350F;margin-bottom:18px;line-height:1.65}\n#au-hp1249 .danger{border-left:3px solid var(--rd);background:#FEF2F2;padding:11px 16px;font-size:12.5px;color:#7F1D1D;margin-bottom:18px;line-height:1.65}\n#au-hp1249 .concl{border-left:4px solid var(--g1);background:var(--ga);padding:14px 20px;font-size:13.5px;color:var(--ch);margin:18px 0;line-height:1.6}\n#au-hp1249 .disc{margin-top:30px;border:1px solid var(--lt);padding:14px 18px;font-size:11px;color:var(--gx);line-height:1.65;font-style:italic;background:var(--gb)}\n#au-hp1249 .foot{border-top:1px solid var(--lt);padding:12px 32px;font-size:11px;color:var(--gx);text-align:center;background:var(--gb)}\n#au-hp1249 .abx-grid{display:grid;grid-template-columns:repeat(2,1fr);gap:12px;margin-bottom:18px}\n#au-hp1249 .abx-card{border:1px solid var(--lt);border-left:4px solid var(--g2);padding:12px 14px;background:var(--gb)}\n#au-hp1249 .abx-name{font-size:12px;font-weight:700;color:var(--g1);margin-bottom:4px}\n#au-hp1249 .abx-target{font-size:11.5px;color:var(--ch)}\n#au-hp1249 .abx-conc{font-size:10px;color:var(--gx);margin-top:3px}\n@media(max-width:640px){\n  #au-hp1249 .hdr{flex-direction:column;padding:18px 20px}\n  #au-hp1249 .strip{grid-template-columns:repeat(3,1fr)}\n  #au-hp1249 .panel{padding:20px}\n  #au-hp1249 .two-col,#au-hp1249 .incub,#au-hp1249 .sig,#au-hp1249 .abx-grid{grid-template-columns:1fr}\n  #au-hp1249 .cards{grid-template-columns:1fr}\n  #au-hp1249 .tab{padding:10px 13px;font-size:11px}\n}\n\u003c\/style\u003e\n\u003cdiv id=\"au-hp1249\"\u003e\n\u003cdiv class=\"hdr\"\u003e\n\u003cdiv class=\"hdr-l\"\u003e\n\u003cdiv class=\"cat\"\u003eSelective Culture Medium · Clinical Microbiology · Gastroenterology\u003c\/div\u003e\n\u003cdiv class=\"pname\"\u003eHelicobacter pylori Selective Medium Base\u003c\/div\u003e\n\u003cdiv class=\"psub\"\u003eColumbia Blood Agar Base + VCTA Selective Supplement\u003c\/div\u003e\n\u003cdiv class=\"badges\"\u003e\n\u003cspan class=\"badge\"\u003ePC2 Pathogen Culture\u003c\/span\u003e \u003cspan class=\"badge\"\u003eMicroaerophilic\u003c\/span\u003e \u003cspan class=\"badge\"\u003eIARC Group I Pathogen\u003c\/span\u003e \u003cspan class=\"badge\"\u003eVancomycin · Trimethoprim · Cefsulodin · Amphotericin B\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hdr-r\"\u003e\n\u003cdiv class=\"brand\"\u003eAuSaMicS\u003c\/div\u003e\n\u003cdiv class=\"brand-s\"\u003eLife Science™\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"strip\"\u003e\n\u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003eCat No.\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003eAS-1249\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003eBase Medium\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003eColumbia Blood Agar\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003eFinal pH\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003e7.3 ± 0.2\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003eAtmosphere\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003eMicroaerophilic\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003eIncubation\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003e37–42 °C \/ 3–7 d\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"tabs\"\u003e\n\u003cbutton class=\"tab active\"\u003eProduct Description\u003c\/button\u003e \u003cbutton class=\"tab\"\u003eTechnical Data Sheet\u003c\/button\u003e \u003cbutton class=\"tab\"\u003eSafety Data Sheet\u003c\/button\u003e \u003cbutton class=\"tab\"\u003eCertificate of Analysis\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c!-- TAB 1: PD --\u003e\n\u003cdiv class=\"panel active\" id=\"au-hp-pd\"\u003e\n\u003cdiv class=\"sh\"\u003eOverview\u003c\/div\u003e\n\u003cp\u003e\u003cem\u003eHelicobacter pylori\u003c\/em\u003e Selective Medium Base is a specialised culture medium for the isolation and cultivation of \u003cem\u003eHelicobacter pylori\u003c\/em\u003e, a microaerophilic Gram-negative spiral bacterium and the primary causative agent of chronic active gastritis, peptic ulcer disease, and gastric adenocarcinoma. Classified as an IARC Group I carcinogen, \u003cem\u003eH. pylori\u003c\/em\u003e colonises the human gastric mucosa and requires enriched, highly selective conditions for successful primary isolation.\u003c\/p\u003e\n\u003cp\u003eThe base medium is Columbia Blood Agar supplemented with 5–10% defibrinated sheep blood (providing haemin, NAD, and growth factors) and a four-antibiotic selective cocktail: \u003cstrong\u003evancomycin\u003c\/strong\u003e (Gram-positive suppression), \u003cstrong\u003etrimethoprim\u003c\/strong\u003e (enteric flora), \u003cstrong\u003ecefsulodin\u003c\/strong\u003e (anti-\u003cem\u003ePseudomonas\u003c\/em\u003e), and \u003cstrong\u003eamphotericin B\u003c\/strong\u003e (antifungal). \u003cem\u003eH. pylori\u003c\/em\u003e is intrinsically resistant to all four antibiotics at concentrations used, permitting preferential recovery from complex clinical specimens.\u003c\/p\u003e\n\u003cdiv class=\"sh\"\u003eApplications\u003c\/div\u003e\n\u003cdiv class=\"cards\"\u003e\n\u003cdiv class=\"card\"\u003e\n\u003cdiv class=\"card-icon\"\u003e🦠\u003c\/div\u003e\n\u003cdiv class=\"card-title\"\u003ePrimary Isolation\u003c\/div\u003e\n\u003cdiv class=\"card-body\"\u003eGold standard culture from gastric biopsy (antrum, corpus, fundus), gastric brushings, and gastric juice specimens for diagnosis and AST.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card\"\u003e\n\u003cdiv class=\"card-icon\"\u003e💊\u003c\/div\u003e\n\u003cdiv class=\"card-title\"\u003eAntibiotic Sensitivity\u003c\/div\u003e\n\u003cdiv class=\"card-body\"\u003eCulture-based susceptibility testing (E-test \/ disk diffusion) for clarithromycin, metronidazole, and levofloxacin resistance profiling per Maastricht V guidelines.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card\"\u003e\n\u003cdiv class=\"card-icon\"\u003e🔬\u003c\/div\u003e\n\u003cdiv class=\"card-title\"\u003eResearch \u0026amp; QC\u003c\/div\u003e\n\u003cdiv class=\"card-body\"\u003eIn vitro pathogenesis studies, eradication confirmation cultures, and proficiency testing for NATA \/ ISO 17025-accredited laboratories.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sh\"\u003eSelective Antibiotic Supplement (VCTA)\u003c\/div\u003e\n\u003cdiv class=\"abx-grid\"\u003e\n\u003cdiv class=\"abx-card\"\u003e\n\u003cdiv class=\"abx-name\"\u003eVancomycin\u003c\/div\u003e\n\u003cdiv class=\"abx-target\"\u003eSuppresses Gram-positive bacteria\u003c\/div\u003e\n\u003cdiv class=\"abx-conc\"\u003e~10 mg\/L · Glycopeptide · Cell wall inhibition\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"abx-card\"\u003e\n\u003cdiv class=\"abx-name\"\u003eTrimethoprim\u003c\/div\u003e\n\u003cdiv class=\"abx-target\"\u003eSuppresses enteric Gram-negative bacilli\u003c\/div\u003e\n\u003cdiv class=\"abx-conc\"\u003e~5 mg\/L · DHFR inhibitor · Folate pathway\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"abx-card\"\u003e\n\u003cdiv class=\"abx-name\"\u003eCefsulodin\u003c\/div\u003e\n\u003cdiv class=\"abx-target\"\u003eInhibits \u003cem\u003ePseudomonas aeruginosa\u003c\/em\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"abx-conc\"\u003e~5 mg\/L · Beta-lactam · Cell wall inhibition\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"abx-card\"\u003e\n\u003cdiv class=\"abx-name\"\u003eAmphotericin B\u003c\/div\u003e\n\u003cdiv class=\"abx-target\"\u003eInhibits yeasts and moulds\u003c\/div\u003e\n\u003cdiv class=\"abx-conc\"\u003e~2 mg\/L · Polyene · Ergosterol binding\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"note\"\u003e\n\u003cem\u003eH. pylori\u003c\/em\u003e is intrinsically resistant to all four antibiotics at concentrations used, enabling highly selective recovery from heavily contaminated gastric specimens.\u003c\/div\u003e\n\u003cdiv class=\"sh\"\u003eColony Identification \u0026amp; Confirmation\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eColony morphology\u003c\/td\u003e\n\u003ctd\u003eSmall (0.5–2 mm), circular, convex, translucent to grey, smooth; non-haemolytic (gamma)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUrease test\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eStrongly positive\u003c\/strong\u003e — rapid urease colour change within 1–4 hours\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOxidase test\u003c\/td\u003e\n\u003ctd\u003ePositive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCatalase test\u003c\/td\u003e\n\u003ctd\u003ePositive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGram stain\u003c\/td\u003e\n\u003ctd\u003eGram-negative spiral \/ curved rods; S-shaped or seagull morphology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMotility\u003c\/td\u003e\n\u003ctd\u003ePositive — corkscrew motility by dark-field or phase-contrast microscopy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolecular confirmation\u003c\/td\u003e\n\u003ctd\u003e16S rRNA PCR or species-specific PCR for definitive identification\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"sh\"\u003eIncubation Requirements\u003c\/div\u003e\n\u003cdiv class=\"incub\"\u003e\n\u003cdiv class=\"ib\"\u003e\n\u003cdiv class=\"lbl\"\u003eStandard\u003c\/div\u003e\n\u003cdiv class=\"temp\"\u003e37–42 °C\u003c\/div\u003e\n\u003cdiv class=\"dur\"\u003e3–7 days · Microaerophilic atmosphere\u003cbr\u003e5–10% CO², 5–10% O², balance N²\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"ib\"\u003e\n\u003cdiv class=\"lbl\"\u003eCritical Requirements\u003c\/div\u003e\n\u003cdiv class=\"temp\"\u003e≥ 95% RH\u003c\/div\u003e\n\u003cdiv class=\"dur\"\u003eHigh humidity essential — prevent desiccation\u003cbr\u003eUse CampyPak or equivalent gas generator\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"warn\"\u003e\n\u003cstrong\u003eAerobic and anaerobic conditions are NOT suitable\u003c\/strong\u003e — \u003cem\u003eH. pylori\u003c\/em\u003e requires strict microaerophilic atmosphere for growth. Standard CO² incubators are insufficient without O² control.\u003c\/div\u003e\n\u003cdiv class=\"sh\"\u003eStorage \u0026amp; Shelf Life\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDehydrated Base\u003c\/td\u003e\n\u003ctd\u003e15–30 °C, dry place, tightly closed, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrepared Plates\u003c\/td\u003e\n\u003ctd\u003e2–8 °C, sealed in plastic bag — use within 2 weeks of preparation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAfter Opening\u003c\/td\u003e\n\u003ctd\u003eReseal immediately; use desiccant sachet if humidity \u0026gt; 60% RH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDo Not Use If\u003c\/td\u003e\n\u003ctd\u003ePowder shows caking or discolouration; plates show contamination, drying, or colour change\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"disc\"\u003e\n\u003cstrong\u003eAuSaMicS Pty Ltd\u003c\/strong\u003e (ABN 56 676 640 467) warrants that this product meets stated specifications at time of manufacture. For laboratory use only. Not intended for human, animal, food, feed, or pharmaceutical use. · 31 Longview CT, Thomastown VIC 3074, Australia · support@ausamics.com · +61 412 520 598 · www.ausamics.com.au\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- TAB 2: TDS --\u003e\n\u003cdiv class=\"panel\" id=\"au-hp-tds\"\u003e\n\u003cdiv class=\"two-col\"\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"sh\"\u003eProduct Identification\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduct Name\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eH. pylori Selective Medium Base\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCatalog No.\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eAS-1249\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLot No.\u003c\/td\u003e\n\u003ctd\u003eHPS260301\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMfg. Date\u003c\/td\u003e\n\u003ctd\u003eMarch 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetest Date\u003c\/td\u003e\n\u003ctd\u003eMarch 2028\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGrade\u003c\/td\u003e\n\u003ctd\u003eMicrobiological \/ Selective\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBase Medium\u003c\/td\u003e\n\u003ctd\u003eColumbia Blood Agar Base\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"sh\"\u003ePhysical Properties\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAppearance (powder)\u003c\/td\u003e\n\u003ctd\u003eHomogeneous; light beige to pale pink\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAppearance (prepared)\u003c\/td\u003e\n\u003ctd\u003eOpaque, red-brown gel (with 5% sheep blood)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003epH (prepared, 25 °C)\u003c\/td\u003e\n\u003ctd\u003e7.3 ± 0.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAgar gel \/ melt\u003c\/td\u003e\n\u003ctd\u003eGels ~32–34 °C \/ Melts ~84–86 °C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLoss on Drying\u003c\/td\u003e\n\u003ctd\u003e≤ 7.0% w\/w\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHaemolysis\u003c\/td\u003e\n\u003ctd\u003eGamma (non-haemolytic) for H. pylori\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sh\"\u003eBase Medium Composition per Litre (Columbia Base)\u003c\/div\u003e\n\u003ctable class=\"dt\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eComponent\u003c\/th\u003e\n\u003cth\u003eFunction\u003c\/th\u003e\n\u003cth\u003eAmount (g\/L)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePeptone (mixed — casein\/meat\/heart)\u003c\/td\u003e\n\u003ctd\u003eNitrogen, amino acids — supports fastidious organisms\u003c\/td\u003e\n\u003ctd\u003e23.00\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCornstarch (soluble)\u003c\/td\u003e\n\u003ctd\u003eCarbon source + protective agent for organism viability\u003c\/td\u003e\n\u003ctd\u003e1.00\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSodium Chloride\u003c\/td\u003e\n\u003ctd\u003eOsmotic balance\u003c\/td\u003e\n\u003ctd\u003e5.00\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAgar (bacteriological grade)\u003c\/td\u003e\n\u003ctd\u003eSolidifying agent\u003c\/td\u003e\n\u003ctd\u003e10.00\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTOTAL (base powder per litre)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e39.00\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDefibrinated sheep blood\u003c\/td\u003e\n\u003ctd\u003eGrowth factors (haemin, NAD), haemolysis indicator — ADD AFTER AUTOCLAVING\u003c\/td\u003e\n\u003ctd\u003e5–10% v\/v\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"sh\"\u003eSelective Antibiotic Supplement\u003c\/div\u003e\n\u003ctable class=\"dt\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eAntibiotic\u003c\/th\u003e\n\u003cth\u003eTypical Concentration\u003c\/th\u003e\n\u003cth\u003eTarget Organisms Suppressed\u003c\/th\u003e\n\u003cth\u003eMechanism\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVancomycin\u003c\/td\u003e\n\u003ctd\u003e10 mg\/L\u003c\/td\u003e\n\u003ctd\u003eGram-positive bacteria\u003c\/td\u003e\n\u003ctd\u003eCell wall synthesis (glycopeptide)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrimethoprim\u003c\/td\u003e\n\u003ctd\u003e5 mg\/L\u003c\/td\u003e\n\u003ctd\u003eEnteric Gram-negative bacilli\u003c\/td\u003e\n\u003ctd\u003eDHFR inhibition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCefsulodin\u003c\/td\u003e\n\u003ctd\u003e5 mg\/L\u003c\/td\u003e\n\u003ctd\u003e\u003cem\u003ePseudomonas aeruginosa\u003c\/em\u003e\u003c\/td\u003e\n\u003ctd\u003eBeta-lactam \/ cell wall\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAmphotericin B\u003c\/td\u003e\n\u003ctd\u003e2 mg\/L\u003c\/td\u003e\n\u003ctd\u003eYeasts and moulds\u003c\/td\u003e\n\u003ctd\u003eErgosterol binding\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"sh\"\u003ePreparation Protocol\u003c\/div\u003e\n\u003col class=\"steps\"\u003e\n\u003cli\u003e\n\u003cspan class=\"sn\"\u003e1\u003c\/span\u003e\u003cspan\u003eSuspend \u003cstrong\u003e39 g\u003c\/strong\u003e of dehydrated Columbia base in 1 L of purified water.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"sn\"\u003e2\u003c\/span\u003e\u003cspan\u003eHeat with agitation until completely dissolved. Bring to a rolling boil for 1 minute.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"sn\"\u003e3\u003c\/span\u003e\u003cspan\u003eAutoclave at \u003cstrong\u003e121 °C (15 psi)\u003c\/strong\u003e for \u003cstrong\u003e15 minutes\u003c\/strong\u003e.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"sn\"\u003e4\u003c\/span\u003e\u003cspan\u003eCool to exactly \u003cstrong\u003e45–50 °C\u003c\/strong\u003e. \u003cem\u003eCritical: above 50 °C will lyse blood cells.\u003c\/em\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"sn\"\u003e5\u003c\/span\u003e\u003cspan\u003eAdd \u003cstrong\u003e5–10% v\/v defibrinated sheep blood\u003c\/strong\u003e (pre-warmed to 45 °C) aseptically. Mix gently — avoid frothing.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"sn\"\u003e6\u003c\/span\u003e\u003cspan\u003eAdd antibiotic selective supplement \u003cstrong\u003easeptically\u003c\/strong\u003e per manufacturer's instructions. Mix gently.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"sn\"\u003e7\u003c\/span\u003e\u003cspan\u003ePour \u003cstrong\u003e15–20 mL\u003c\/strong\u003e per 90 mm plate under laminar flow. Allow to solidify.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"sn\"\u003e8\u003c\/span\u003e\u003cspan\u003eDry at 37 °C for 30–45 min. Store at 2–8 °C in sealed bags. Use within 2 weeks.\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cdiv class=\"sh\"\u003eQuality Control Specifications\u003c\/div\u003e\n\u003ctable class=\"dt\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eParameter\u003c\/th\u003e\n\u003cth\u003eSpecification\u003c\/th\u003e\n\u003cth\u003eMethod\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAppearance (powder)\u003c\/td\u003e\n\u003ctd\u003eHomogeneous; light beige to pale pink\u003c\/td\u003e\n\u003ctd\u003eVisual inspection\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003epH (prepared, 25 °C)\u003c\/td\u003e\n\u003ctd\u003e7.1 – 7.5\u003c\/td\u003e\n\u003ctd\u003ePotentiometry\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGrowth — \u003cem\u003eH. pylori\u003c\/em\u003e ATCC 43504\u003c\/td\u003e\n\u003ctd\u003eGood growth; translucent colonies at day 3–5 (37 °C, microaerophilic)\u003c\/td\u003e\n\u003ctd\u003eCulture test\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInhibition — \u003cem\u003eE. coli\u003c\/em\u003e ATCC 25922\u003c\/td\u003e\n\u003ctd\u003eComplete \/ ≥ 99% inhibition\u003c\/td\u003e\n\u003ctd\u003eSelectivity test\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInhibition — \u003cem\u003eC. albicans\u003c\/em\u003e ATCC 10231\u003c\/td\u003e\n\u003ctd\u003eComplete inhibition\u003c\/td\u003e\n\u003ctd\u003eAntifungal selectivity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHaemolysis pattern\u003c\/td\u003e\n\u003ctd\u003eGamma (non-haemolytic) for \u003cem\u003eH. pylori\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eVisual — plate check\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSterility\u003c\/td\u003e\n\u003ctd\u003eNo growth at 14 days (aerobic, 30–35 °C)\u003c\/td\u003e\n\u003ctd\u003eIncubation check\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"disc\"\u003e\n\u003cstrong\u003eAuSaMicS Pty Ltd\u003c\/strong\u003e (ABN 56 676 640 467) · 31 Longview CT, Thomastown VIC 3074, Australia · support@ausamics.com · +61 412 520 598 · www.ausamics.com.au\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- TAB 3: SDS --\u003e\n\u003cdiv class=\"panel\" id=\"au-hp-sds\"\u003e\n\u003cdiv class=\"warn\"\u003e\n\u003cstrong\u003eSafety Data Sheet — GHS Format (Australian WHS Regulations 2017)\u003c\/strong\u003e\u003cbr\u003eIssue Date: March 2026 · Rev: 1.0 · Prepared in accordance with WHS Regulations and GHS 7th Revision.\u003c\/div\u003e\n\u003cdiv class=\"danger\"\u003e\n\u003cstrong\u003eBiological Hazard:\u003c\/strong\u003e This medium is designed to culture \u003cem\u003eH. pylori\u003c\/em\u003e — an \u003cstrong\u003eIARC Group I carcinogen and Risk Group 2 human pathogen\u003c\/strong\u003e. PC2 containment required. All prepared medium and cultures must be treated as biohazardous. Follow AS\/NZS 2243.3:2010.\u003cbr\u003e\u003cstrong\u003eReproductive Toxicant:\u003c\/strong\u003e Trimethoprim (H360) — pregnant workers must avoid handling.\u003c\/div\u003e\n\u003cdiv class=\"sh\"\u003eSection 1 — Identification\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduct Name\u003c\/td\u003e\n\u003ctd\u003eHelicobacter pylori Selective Medium Base\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCatalog No.\u003c\/td\u003e\n\u003ctd\u003eAS-1249\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntended Use\u003c\/td\u003e\n\u003ctd\u003eSelective microbiological culture medium — PC2 laboratory use only\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupplier\u003c\/td\u003e\n\u003ctd\u003eAuSaMicS Pty Ltd, 31 Longview CT, Thomastown VIC 3074, Australia\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePhone \/ Emergency\u003c\/td\u003e\n\u003ctd\u003e+61 412 520 598 · Poisons Centre: 13 11 26 (24h)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmail \/ Web\u003c\/td\u003e\n\u003ctd\u003esupport@ausamics.com · www.ausamics.com.au\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"sh\"\u003eSection 2 — Hazard Identification\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGHS Classification\u003c\/td\u003e\n\u003ctd\u003eH315 (skin irritation) · H319 (eye irritation) · \u003cstrong\u003eH360 (reproductive toxicant Cat.2 — trimethoprim)\u003c\/strong\u003e · H335 (respiratory irritation)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSignal Word\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eWARNING\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrecautionary\u003c\/td\u003e\n\u003ctd\u003eP201 · P260 · P264 · P280 · P308+P313 · P501\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiological Hazard\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePC2 required.\u003c\/strong\u003e \u003cem\u003eH. pylori\u003c\/em\u003e = IARC Group I carcinogen · Risk Group 2. All cultures biohazardous.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"sh\"\u003eSection 3 — Composition\u003c\/div\u003e\n\u003ctable class=\"dt\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eComponent\u003c\/th\u003e\n\u003cth\u003eCAS No.\u003c\/th\u003e\n\u003cth\u003eProportion (w\/w)\u003c\/th\u003e\n\u003cth\u003eGHS Classification\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAgar (bacteriological)\u003c\/td\u003e\n\u003ctd\u003e9002-18-0\u003c\/td\u003e\n\u003ctd\u003e~25.6%\u003c\/td\u003e\n\u003ctd\u003eNot classified\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePeptone (mixed)\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e~58.9%\u003c\/td\u003e\n\u003ctd\u003eNot classified\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCornstarch\u003c\/td\u003e\n\u003ctd\u003e9005-25-8\u003c\/td\u003e\n\u003ctd\u003e~2.6%\u003c\/td\u003e\n\u003ctd\u003eNot classified\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSodium Chloride\u003c\/td\u003e\n\u003ctd\u003e7647-14-5\u003c\/td\u003e\n\u003ctd\u003e~12.8%\u003c\/td\u003e\n\u003ctd\u003eNot classified\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVancomycin HCl\u003c\/td\u003e\n\u003ctd\u003e1404-93-9\u003c\/td\u003e\n\u003ctd\u003e\u0026lt; 0.1%\u003c\/td\u003e\n\u003ctd\u003eH315 · H319 · H335\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrimethoprim\u003c\/td\u003e\n\u003ctd\u003e738-70-5\u003c\/td\u003e\n\u003ctd\u003e\u0026lt; 0.1%\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eH360 (Cat. 2)\u003c\/strong\u003e · H315 · H319\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCefsulodin sodium\u003c\/td\u003e\n\u003ctd\u003e52152-93-9\u003c\/td\u003e\n\u003ctd\u003e\u0026lt; 0.1%\u003c\/td\u003e\n\u003ctd\u003eH315 · H317 · H319\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAmphotericin B\u003c\/td\u003e\n\u003ctd\u003e1397-89-3\u003c\/td\u003e\n\u003ctd\u003e\u0026lt; 0.1%\u003c\/td\u003e\n\u003ctd\u003eH315 · H317 · H319 · H335\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDefibrinated sheep blood\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e5–10% v\/v (supplement)\u003c\/td\u003e\n\u003ctd\u003eBiological material — PC2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"sh\"\u003eSections 4–8 — First Aid, Fire, Spill, Handling, PPE\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eInhalation\u003c\/td\u003e\n\u003ctd\u003eRemove to fresh air. Trimethoprim: avoid repeated inhalation (reproductive toxicant). Seek advice if symptomatic.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSkin Contact\u003c\/td\u003e\n\u003ctd\u003eWash with soap and water ≥ 15 min. Remove contaminated clothing. Seek advice if sensitisation reaction (cefsulodin \/ amphotericin B).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEye Contact\u003c\/td\u003e\n\u003ctd\u003eRinse with copious water ≥ 15 min, holding eyelids open. Seek prompt medical attention.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIngestion\u003c\/td\u003e\n\u003ctd\u003eDo not induce vomiting. Rinse mouth. Seek medical advice. Show SDS to physician.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiological Spill\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eBIOHAZARD:\u003c\/strong\u003e Apply 1% hypochlorite or 70% ethanol. Contact time ≥ 30 min. Autoclave all waste. Report per institutional biosafety policy.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFlash Point\u003c\/td\u003e\n\u003ctd\u003eNot applicable (non-flammable powder)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEngineering Controls\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eClass II BSC mandatory\u003c\/strong\u003e for all culture work. Local exhaust ventilation when weighing powder.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRespiratory PPE\u003c\/td\u003e\n\u003ctd\u003eP2 mask when generating dust; PAPR for high-risk procedures\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHand Protection\u003c\/td\u003e\n\u003ctd\u003eNitrile gloves — double-glove for culture work\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePregnancy Warning\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eTrimethoprim H360:\u003c\/strong\u003e Pregnant workers or those planning pregnancy MUST avoid handling. Seek occupational health advice.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"sh\"\u003eSections 9–12 — Properties, Stability, Toxicology, Ecology\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePhysical State\u003c\/td\u003e\n\u003ctd\u003eSolid (powder) \/ Opaque gel (prepared with blood)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003epH (prepared)\u003c\/td\u003e\n\u003ctd\u003e7.3 ± 0.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReproductive Toxicity\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eH360 — Trimethoprim: suspected reproductive toxicant (Category 2)\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSkin\/Eye Irritation\u003c\/td\u003e\n\u003ctd\u003eH315 \/ H319 — antibiotic components\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSensitisation\u003c\/td\u003e\n\u003ctd\u003eCefsulodin (beta-lactam cross-reaction risk); amphotericin B sensitisation possible\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiological Hazard\u003c\/td\u003e\n\u003ctd\u003e\n\u003cem\u003eH. pylori\u003c\/em\u003e: IARC Group I carcinogen; Risk Group 2 organism\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAquatic Toxicity\u003c\/td\u003e\n\u003ctd\u003eAmphotericin B and cefsulodin — potentially toxic to aquatic organisms; prevent discharge\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAntibiotic Resistance\u003c\/td\u003e\n\u003ctd\u003ePrevent environmental discharge — antibiotic resistance gene dissemination risk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"sh\"\u003eSections 13–15 — Disposal, Transport, Regulatory\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWaste Classification\u003c\/td\u003e\n\u003ctd\u003eClinical \/ biohazardous waste — contains antibiotic agents and is designed for pathogen culture\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrepared Medium (used)\u003c\/td\u003e\n\u003ctd\u003eAutoclave 134 °C \/ 18 min or 121 °C \/ 30 min. Dispose as clinical waste per AS\/NZS 3816:1998.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSharps\u003c\/td\u003e\n\u003ctd\u003eApproved sharps containers. Do not recap needles.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTransport (cultures)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eUN 3373\u003c\/strong\u003e — Biological Substance Category B. IATA P650 packing instructions apply.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAICS \/ SUSMP\u003c\/td\u003e\n\u003ctd\u003eAll components on AICS. Trimethoprim: Schedule 4; Amphotericin B: Schedule 4 — supplied for laboratory use only.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiosafety Level\u003c\/td\u003e\n\u003ctd\u003e\n\u003cem\u003eH. pylori\u003c\/em\u003e: Risk Group 2 per AS\/NZS 2243.3:2010 — PC2 containment required\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWHS Regulations\u003c\/td\u003e\n\u003ctd\u003eHazardous chemicals (trimethoprim H360, antibiotics) + biological pathogen — WHS Regulations 2017 apply\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"disc\"\u003e\n\u003cstrong\u003eAuSaMicS Pty Ltd\u003c\/strong\u003e (ABN 56 676 640 467) · 31 Longview CT, Thomastown VIC 3074, Australia · support@ausamics.com · +61 412 520 598 · www.ausamics.com.au\u003cbr\u003eThis SDS is prepared in accordance with Australian WHS Regulations and GHS (7th Rev.). For PC2 laboratory use only.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- TAB 4: COA --\u003e\n\u003cdiv class=\"panel\" id=\"au-hp-coa\"\u003e\n\u003cdiv class=\"two-col\"\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"sh\"\u003eProduct Details\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduct Name\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eH. pylori Selective Medium Base\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCatalog No.\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eAS-1249\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLot No.\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eHPS260301\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMfg. Date\u003c\/td\u003e\n\u003ctd\u003eMarch 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetest Date\u003c\/td\u003e\n\u003ctd\u003eMarch 2028\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGrade\u003c\/td\u003e\n\u003ctd\u003eMicrobiological \/ Selective\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBase\u003c\/td\u003e\n\u003ctd\u003eColumbia Blood Agar + VCTA Supplement\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"sh\"\u003eDocument Information\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOA No.\u003c\/td\u003e\n\u003ctd\u003eCOA-AS-1249-L001\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIssue Date\u003c\/td\u003e\n\u003ctd\u003eMarch 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIssued By\u003c\/td\u003e\n\u003ctd\u003eAuSaMicS Quality Control\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTest Ref.\u003c\/td\u003e\n\u003ctd\u003eIn-house \/ ATCC reference strains\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sh\"\u003eTest Results \u0026amp; Analytical Data\u003c\/div\u003e\n\u003ctable class=\"dt\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTest Parameter\u003c\/th\u003e\n\u003cth\u003eSpecification\u003c\/th\u003e\n\u003cth\u003eMethod\u003c\/th\u003e\n\u003cth\u003eResult\u003c\/th\u003e\n\u003cth\u003eStatus\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAppearance (powder)\u003c\/td\u003e\n\u003ctd\u003eHomogeneous; light beige to pale pink; no lumps\u003c\/td\u003e\n\u003ctd\u003eVisual inspection\u003c\/td\u003e\n\u003ctd\u003eConforms\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAppearance (prepared)\u003c\/td\u003e\n\u003ctd\u003eOpaque, red-brown gel; homogeneous; no contamination\u003c\/td\u003e\n\u003ctd\u003eVisual — plate check\u003c\/td\u003e\n\u003ctd\u003eConforms\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003epH (prepared, 25 °C)\u003c\/td\u003e\n\u003ctd\u003e7.1 – 7.5\u003c\/td\u003e\n\u003ctd\u003ePotentiometry (ISO 10523)\u003c\/td\u003e\n\u003ctd\u003e7.3\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGel strength (prepared)\u003c\/td\u003e\n\u003ctd\u003eFirm gel; no syneresis or collapse\u003c\/td\u003e\n\u003ctd\u003eVisual — plate check\u003c\/td\u003e\n\u003ctd\u003eFirm\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLoss on Drying\u003c\/td\u003e\n\u003ctd\u003e≤ 7.0% w\/w\u003c\/td\u003e\n\u003ctd\u003e105 °C \/ 2 h (gravimetric)\u003c\/td\u003e\n\u003ctd\u003e3.9%\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGrowth — \u003cem\u003eH. pylori\u003c\/em\u003e ATCC 43504\u003c\/td\u003e\n\u003ctd\u003eGood growth; small translucent colonies at day 3–5 (37 °C, microaerophilic)\u003c\/td\u003e\n\u003ctd\u003eMicroaerophilic culture\u003c\/td\u003e\n\u003ctd\u003eGood growth\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInhibition — \u003cem\u003eE. coli\u003c\/em\u003e ATCC 25922\u003c\/td\u003e\n\u003ctd\u003eComplete \/ ≥ 99% inhibition (aerobic, 37 °C, 48 h)\u003c\/td\u003e\n\u003ctd\u003eSelectivity test\u003c\/td\u003e\n\u003ctd\u003eComplete\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInhibition — \u003cem\u003eC. albicans\u003c\/em\u003e ATCC 10231\u003c\/td\u003e\n\u003ctd\u003eComplete inhibition\u003c\/td\u003e\n\u003ctd\u003eAntifungal selectivity\u003c\/td\u003e\n\u003ctd\u003eComplete\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHaemolysis pattern\u003c\/td\u003e\n\u003ctd\u003eGamma (non-haemolytic) for \u003cem\u003eH. pylori\u003c\/em\u003e\n\u003c\/td\u003e\n\u003ctd\u003eVisual — plate check\u003c\/td\u003e\n\u003ctd\u003eGamma\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSterility (prepared medium)\u003c\/td\u003e\n\u003ctd\u003eNo growth at 14 days (aerobic, 30–35 °C)\u003c\/td\u003e\n\u003ctd\u003eIncubation sterility check\u003c\/td\u003e\n\u003ctd\u003eNo growth\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePerformance Compliance\u003c\/td\u003e\n\u003ctd\u003eSupports \u003cem\u003eH. pylori\u003c\/em\u003e growth; inhibits contaminants per specification\u003c\/td\u003e\n\u003ctd\u003ePerformance review\u003c\/td\u003e\n\u003ctd\u003eConforms\u003c\/td\u003e\n\u003ctd\u003e\u003cspan class=\"conform\"\u003eCONFORM\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"concl\"\u003e\n\u003cstrong style=\"color: #1a4731;\"\u003eConclusion:\u003c\/strong\u003e Lot HPS260301 has been tested against all release specifications for \u003cem\u003eH. pylori\u003c\/em\u003e Selective Agar. Performance-verified using \u003cem\u003eH. pylori\u003c\/em\u003e ATCC 43504 under microaerophilic conditions. This lot is \u003cstrong style=\"color: #1a4731;\"\u003eRELEASED for use\u003c\/strong\u003e.\u003c\/div\u003e\n\u003cdiv class=\"sig\"\u003e\n\u003cdiv class=\"sigb\"\u003e\n\u003cdiv class=\"sname\"\u003eQuality Control Analyst\u003c\/div\u003e\n\u003cdiv class=\"srole\"\u003eAuSaMicS Quality Control Department\u003c\/div\u003e\n\u003cdiv class=\"sdate\"\u003eDate: March 2026  |  Signature: _______________\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sigb\"\u003e\n\u003cdiv class=\"sname\"\u003eQuality Manager\u003c\/div\u003e\n\u003cdiv class=\"srole\"\u003eAuSaMicS Pty Ltd\u003c\/div\u003e\n\u003cdiv class=\"sdate\"\u003eDate: March 2026  |  Signature: _______________\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"disc\"\u003e\n\u003cstrong\u003eAuSaMicS Pty Ltd\u003c\/strong\u003e (ABN 56 676 640 467) warrants this product meets specifications at time of manufacture. For laboratory use only. Not intended for human, animal, food, feed, or pharmaceutical use. AuSaMicS Pty Ltd shall not be held liable for any damages resulting from use outside the intended application. · 31 Longview CT, Thomastown VIC 3074, Australia · support@ausamics.com · +61 412 520 598 · www.ausamics.com.au\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"foot\"\u003eAuSaMicS Pty Ltd  ·  ABN 56 676 640 467  ·  31 Longview CT, Thomastown VIC 3074, Australia  ·  support@ausamics.com  ·  +61 412 520 598  ·  www.ausamics.com.au\u003c\/div\u003e\n\u003cscript\u003e\nfunction auHP(id,btn){\n  var panels=document.querySelectorAll('#au-hp1249 .panel');\n  var tabs=document.querySelectorAll('#au-hp1249 .tab');\n  for(var i=0;i\u003cpanels.length;i++) panels[i].classList.remove('active');\n  for(var i=0;i\u003ctabs.length;i++) tabs[i].classList.remove('active');\n  document.getElementById('au-hp-'+id).classList.add('active');\n  btn.classList.add('active');\n}\n\u003c\/script\u003e\n\u003c\/div\u003e","brand":"Ausamics Life Science","offers":[{"title":"100 g","offer_id":48293527519487,"sku":"AS-1247-100G","price":37.0,"currency_code":"AUD","in_stock":true},{"title":"500 g","offer_id":48293527552255,"sku":"AS-1247-500G","price":117.0,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0771\/1087\/0271\/files\/HelicobacterPyloriSelectiveAgarBase.png?v=1773655156","url":"https:\/\/ausamics.com.au\/products\/helicobacter-pylori-selective-agar","provider":"AuSaMicS","version":"1.0","type":"link"}